Updated:
Epizyme, Inc.
Epizyme, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001571498, and its reported industry is...
Overview
Epizyme, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001571498, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-01, it reported annual revenue of USD 37,427,000; net income of USD -251,122,000; total assets of USD 289,000,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Epizyme, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001571498
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2021USD | $37.4M | -$251.1M | $289.0M | $98.3M | -$226.9M | |
| FY2020USD | $15.8M | -$231.7M | $473.6M | $168.2M | -$206.3M | |
| FY2019USD | $23.8M | -$170.3M | $424.6M | $139.5M | -$147.2M | |
| FY2018USD | $21.7M | -$123.6M | $275.5M | $86.7M | -$121.6M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Epizyme, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.